Glycoengineering of Natural Killer Cells with CD22 Ligands for Enhanced Anticancer Immunotherapy

[Image: see text] Adoptive transfer of immune cells is being actively pursued for cancer treatment. Natural killer (NK) cells, a class of cytotoxic immune cells, generally lack inherent selectivities toward cancer. To bestow tumor-targeting abilities and enhance anticancer efficacy, a new strategy i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xianwu, Lang, Shuyao, Tian, Yunpeng, Zhang, Jianghong, Yan, Xu, Fang, Zhihong, Weng, Jian, Lu, Na, Wu, Xuanjun, Li, Tianlu, Cao, Hongzhi, Li, Zhu, Huang, Xuefei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099595/
https://www.ncbi.nlm.nih.gov/pubmed/32232138
http://dx.doi.org/10.1021/acscentsci.9b00956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099595/
https://www.ncbi.nlm.nih.gov/pubmed/32232138
http://dx.doi.org/10.1021/acscentsci.9b00956

Ejemplares similares